Edward F Mc Clay

Title: Edward F Mc Clay: Innovator in Cancer Treatment

Introduction

Edward F Mc Clay is a notable inventor based in Encinitas, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development efforts. His work focuses on creating effective therapies for human cancers, showcasing his dedication to improving patient outcomes.

Latest Patents

Edward F Mc Clay holds a patent for a novel composition known as "Combination cisplatin/tamoxifen therapy for human cancers." This invention provides a synergistic and cytotoxic composition that combines a platinum-containing antineoplastic agent with tamoxifen. The patent outlines methods for treating a wide variety of human cancers, particularly non-melanoma cancers, using this pharmacologic combination. Additionally, it addresses methods for reducing or overcoming resistance to platinum-containing antineoplastic agents, such as cisplatin.

Career Highlights

Throughout his career, Edward F Mc Clay has been associated with the Research Development Foundation, where he has contributed to groundbreaking research in cancer therapies. His work has been instrumental in advancing the understanding and treatment of various cancers, making a lasting impact in the medical field.

Collaborations

Edward F Mc Clay has collaborated with Stephen B Howell, further enhancing the research efforts in cancer treatment. Their partnership exemplifies the importance of teamwork in scientific innovation.

Conclusion

Edward F Mc Clay's contributions to cancer treatment through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in the field of oncology.